Inmunómica traslacional en neoplasias hematológicas
Roswell Park Cancer Institute
Búfalo, Estados UnidosPublications en collaboration avec des chercheurs de Roswell Park Cancer Institute (5)
2021
-
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Leukemia, Vol. 35, Núm. 1, pp. 18-30
2016
-
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
The Lancet Oncology, Vol. 17, Núm. 8, pp. e328-e346
2015
-
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Biology of Blood and Marrow Transplantation, Vol. 21, Núm. 12, pp. 2039-2051
2012
-
IMWG consensus on maintenance therapy in multiple myeloma
Blood, Vol. 119, Núm. 13, pp. 3003-3015
-
Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment
Clinical Cancer Research, Vol. 18, Núm. 8, pp. 2145-2163